An agreement between the Google[x] resesearch lab and pharmaceutical giant Novartis will license the technology for actual medical use for people with diabetes and other conditions.
The companies are seeking ways to integrate health sensors and apps into their wearable devices, including those to measure glucose levels in a non-invasive way.
What if people with diabetes didn't have to prick their fingers several times a day to conduct blood sugar tests -- but instead could simply wear contacts?
Google is developing a "smart" contact lens to monitor blood sugar levels through the wearer's tears.
Researchers at Princeton University have developed a 3D printer that can print LEDs in layers -- and it could one day print contact lenses that incorporate heads-up displays.
Scientists at Stanford are working on a vaccine to stop a type 1 diabetic's immune system from attacking the cells that make insulin.
Diabetics can have a "fruity" odor to their breath that indicates high glucose levels, and chemists at the University of Pittsburgh say this biomarker alone can diagnose the disease.
The search giant will take over 1,000 acres of Moffett Field, down the street from Google's headquarters, to research robotics, space exploration and aviation.
It's not about the device you buy. The real value is in the data it produces.
Nanotechnology could remove the finger prick from the daily routine of people with diabetes with an injectable gel that monitors blood-sugar levels and automatically secretes insulin.